INHIBRX BIOSCIENCES, INC. (INBX) Return on equity 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1752.2%FY2025 · since FY2023: -554.8% → -1752.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1752.2% | -3015.5 pp |
| FY2024 | 1263.3% | +1818.1 pp |
| FY2023 | -554.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating incomeINBX Operating marginINBX Operating cash flowINBX Free cash flowINBX Capital expendituresINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Total liabilitiesINBX Shareholders’ equityINBX overview →